FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1569007102> ?p ?o ?g. }

• W1569007102 endingPage "351" @default.
• W1569007102 startingPage "351" @default.
• W1569007102 abstract "Many features of dogs make them suitable animal models to study new therapeutic approaches for human diseases: a large body mass, a long life span and spontaneous diseases such as chronic renal failure (CRF) that leads to anemia. This, and the longevity of canine red blood cells (RBC) comparable to that of humans, render dogs particularly suitable to develop new treatments of CRF-induced anemia. In contrast, rodents differ from humans by a much smaller body mass, shorter longevity of RBC (43 days) and the absence of spontaneous diseases resembling those of people. Current treatment of CRF-induced anemia in people (and dogs) consists of repeated injections of recombinant human EPO (rhEPO), which incurs high costs and specialized personnel. Our hypothesis is that the implantation of an “organoid” composed of autologous cells embedded in an organic matrix and engineered to produce and systemically release EPO can correct CRF-induced anemia in dogs for a long period, replacing the need for repeated injections of rhEPO. As a first step towards this goal, we demonstrated the feasibility of this approach in normal dogs. We used bone marrow stromal cells (BMSCs) for the sustained production of EPO in vivo because these cells are easily accessible, transduceable and expandable in vitro. We isolated and transduced canine BMSCs with the canine EPO gene using a bicistronic retrovector. Using a MOI of 60, the transduction efficiency was 60 to 90% as analysed by FACS; the in vitro production and release of canine EPO was verified by Western blot and measured by ELISA (2 U of EPO/106 cells/24 hrs). The incorporation of engineered cells in a biocompatible solid matrix makes it possible to remove the implant in case of over expression of the transgene or other complications. To demonstrate the functionality of the secreted protein, the canine EPO-engineered BMSCs were embedded in bovine type I collagen (Inamed™), and the resulting organoid was implanted in 5 NOD-SCID mice (7 × 106cells/500 μl collagen/mouse). Four control mice were treated identically except that the implanted BMSCs (from the same dog) were transduced with empty retroparticles. The hematocrit (Ht) of treated mice increased from 53% to 88% in 33 days and remained elevated over 3 months following implantation. The canine EPO-engineered BMSC were embedded within the same matrix and implanted s.c. in the respective donor dogs. The number of embedded BMSCs and volume of implants were optimized: 32 implants were given in 11 injections (3 implants per injection, each implant containing 4 × 106 BMSCs). This protocol has been implemented in 3 dogs whose Ht has increased from 42 (SD: ±6.9) to 55 (SD: ±2) within 12 days and has remained elevated for 4 weeks. These results clearly demonstrate the feasibility of cellular therapy in large immunocompetent mammals, a crucial step towards its application in people. We will next carry out the optimized protocol on canine and feline patients affected by CRF-induced anemia." @default.
• W1569007102 created "2016-06-24" @default.
• W1569007102 date "2004-05-01" @default.
• W1569007102 modified "2023-09-24" @default.
• W1569007102 title "Autologous canine bone marrow stromal cells retrovirally engineered with the canine EPO gene and implanted in vivo in a collagen matrix produce and release systemically functional EPO over a prolonged period" @default.
• W1569007102 doi "https://doi.org/10.1016/j.ymthe.2004.06.824" @default.
• W1569007102 hasPublicationYear "2004" @default.
• W1569007102 type Work @default.
• W1569007102 sameAs 1569007102 @default.
• W1569007102 citedByCount "1" @default.
• W1569007102 crossrefType "journal-article" @default.
• W1569007102 hasBestOaLocation W15690071021 @default.
• W1569007102 hasConcept C104317684 @default.
• W1569007102 hasConcept C111599444 @default.
• W1569007102 hasConcept C126322002 @default.
• W1569007102 hasConcept C150903083 @default.
• W1569007102 hasConcept C16930146 @default.
• W1569007102 hasConcept C202751555 @default.
• W1569007102 hasConcept C203014093 @default.
• W1569007102 hasConcept C207001950 @default.
• W1569007102 hasConcept C2778248108 @default.
• W1569007102 hasConcept C2778534260 @default.
• W1569007102 hasConcept C2780007613 @default.
• W1569007102 hasConcept C502942594 @default.
• W1569007102 hasConcept C55493867 @default.
• W1569007102 hasConcept C71924100 @default.
• W1569007102 hasConcept C86803240 @default.
• W1569007102 hasConceptScore W1569007102C104317684 @default.
• W1569007102 hasConceptScore W1569007102C111599444 @default.
• W1569007102 hasConceptScore W1569007102C126322002 @default.
• W1569007102 hasConceptScore W1569007102C150903083 @default.
• W1569007102 hasConceptScore W1569007102C16930146 @default.
• W1569007102 hasConceptScore W1569007102C202751555 @default.
• W1569007102 hasConceptScore W1569007102C203014093 @default.
• W1569007102 hasConceptScore W1569007102C207001950 @default.
• W1569007102 hasConceptScore W1569007102C2778248108 @default.
• W1569007102 hasConceptScore W1569007102C2778534260 @default.
• W1569007102 hasConceptScore W1569007102C2780007613 @default.
• W1569007102 hasConceptScore W1569007102C502942594 @default.
• W1569007102 hasConceptScore W1569007102C55493867 @default.
• W1569007102 hasConceptScore W1569007102C71924100 @default.
• W1569007102 hasConceptScore W1569007102C86803240 @default.
• W1569007102 hasLocation W15690071021 @default.
• W1569007102 hasOpenAccess W1569007102 @default.
• W1569007102 hasPrimaryLocation W15690071021 @default.
• W1569007102 hasRelatedWork W2001337201 @default.
• W1569007102 hasRelatedWork W2013842389 @default.
• W1569007102 hasRelatedWork W2038751394 @default.
• W1569007102 hasRelatedWork W2392599473 @default.
• W1569007102 hasRelatedWork W2395603459 @default.
• W1569007102 hasRelatedWork W2416600575 @default.
• W1569007102 hasRelatedWork W2422399853 @default.
• W1569007102 hasRelatedWork W3184048039 @default.
• W1569007102 hasRelatedWork W2230988230 @default.
• W1569007102 hasRelatedWork W3031087399 @default.
• W1569007102 hasVolume "9" @default.
• W1569007102 isParatext "false" @default.
• W1569007102 isRetracted "false" @default.
• W1569007102 magId "1569007102" @default.
• W1569007102 workType "article" @default.